ALGENEX promotes the construction of a new pilot plant dedicated to the production of injectable drugs from baculovirus-based insect breeding (BVES) in insect cells; adapting to GMP and FDA regulations.
AXIOM performed the necessary engineering, basic project, detailed project, all related to licenses and permits, demolition project, environmental impact study, bid management, construction management and coordination of health and safety on site..
